The basophil activation test in the diagnosis of immediate drug hypersensitivity

Expert Review of Clinical Immunology

Volumn 7, Issue 3, 2011, Pages 349-355

  Leysen, Julie ^a   Sabato, Vito ^a   Verweij, Marjoke M ^a   De Knop, Kathleen J ^a   Bridts, Chris H ^a   De Clerck, Luc S ^a   Ebo, Didier G ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

basophil activation test; CD203c; CD63; drug allergy; flow cytometry; specific IgE

Indexed keywords

ACETYLSALICYLIC ACID; BETA LACTAM ANTIBIOTIC; CARBOXYMETHYLCELLULOSE; CD63 ANTIGEN; CHLORHEXIDINE; CIPROFLOXACIN; CLAVULANIC ACID; CYCLOOXYGENASE 1; IMMUNOGLOBULIN E; LEVOFLOXACIN; MITOGEN ACTIVATED PROTEIN KINASE; MOXIFLOXACIN; NEUROMUSCULAR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SYNAPTOPHYSIN;

ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANTIGEN PRESENTING CELL; ASTHMA; BASOPHIL; BASOPHIL ACTIVATION TEST; CELL ACTIVATION; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LEUKOCYTE; MORBIDITY; MORTALITY; PHENOTYPE; PROVOCATION TEST; REVIEW; SENSITIVITY AND SPECIFICITY;

BASOPHIL DEGRANULATION TEST; DRUG HYPERSENSITIVITY; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, IMMEDIATE;

EID: 79957531962     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.14     Document Type: Review

References (54)

1. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr. Opin. Allergy Clin. Immunol. 5, 309-316 (2005). (Pubitemid 41017644)
2. Hayward RA, Hofer TP. Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA 286, 415-420 (2001). (Pubitemid 32681483)
3. Aberer W, Kranke B. Provocation tests in drug hypersensitivity. Immunol. Allergy Clin. North Am. 29, 567-584 (2009).
4. Schnyder B, Pichler WJ. Mechanisms of drug-induced allergy. Mayo Clin. Proc. 84, 268-272 (2009).
5. Sanz ML, Maselli JP, Gamboa PM, Oehling A, Dieguez I, De Weck AL. Flow cytometric basophil activation test: a review. J. Investig. Allergol. Clin. Immunol. 12, 143-154 (2002). (Pubitemid 35334409)
6. Ebo DG, Bridts CH, Hagendorens MM, Aerts NE, De Clerck LS, Stevens WJ. Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin. Cytom. 74, 201-210 (2008). (Pubitemid 352007317)
7. Verweij MM, De Knop KJ, Bridts CH, De Clerck LS, Stevens WJ, Ebo DG. p38 mitogen-activated protein kinase signal transduction in the diagnosis and follow up of immunotherapy of wasp venom allergy. Cytometry B Clin. Cytom. 78, 302-307 (2010).
8. Sabato V, Verweij MM, Bridts CH et al. Human basophils express the inhibitory receptor CD300a (IRp60).J. Allergy Clin. Immunol. 127(2), AB75 (2011) (Abstract 283).
9. Ebo DG, Hagendorens MM, Bridts CH, Schuerwegh AJ, De Clerck LS, Stevens WJ. Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy. Cytometry B Clin. Cytom. 64, 28-33 (2005). (Pubitemid 40960409)
10. Ebo DG, Sainte-Laudy J, Bridts CH et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 61, 1028-1039 (2006). (Pubitemid 44175209)
11. Hausmann OV, Gentinetta T, Bridts CH, Ebo DG. The basophil activation test in immediate-type drug allergy. Immunol. Allergy Clin. North Am. 29, 555-566 (2009).
12. Abuaf N, Rajoely B, Ghazouani E et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J. Allergy Clin. Immunol. 104, 411-418 (1999). (Pubitemid 29420440)
13. Sudheer PS, Hall JE, Read GF, Rowbottom AW, Williams PE. Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaesthesia 60, 251-256 (2005). (Pubitemid 40310206)
14. Kvedariene V, Kamey S, Ryckwaert Y et al. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils. Allergy 61, 311-315 (2006). (Pubitemid 43381807)
15. Sainte-Laudy J, Orsel I. Interest of a new flow cytometric protocol applied to diagnosis and prevention of per anaesthetic accidents induced by neuromuscular blockers. Rev. Fr. Allergol. 48, 470-475 (2008).
16. Monneret G, Benoit Y, Debard AL, Gutowski MC, Topenot I, Bienvenu J. Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin. Immunol. 102, 192-199 (2002). (Pubitemid 34171519)
17. Sanz ML, Gamboa PM, Antepara I et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to b lactam antibiotics. Clin. Exp. Allergy 32, 277-286 (2002). (Pubitemid 34429608)
18. Torres MJ, Padial A, Mayorga C et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin. Exp. Allergy 34, 1768-1775 (2004). (Pubitemid 39551532)
19. Abuaf N, Rostane H, Rajoely B et al. Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin. Exp. Allergy 38, 921-928 (2008). (Pubitemid 351725844)
20. Eberlein B, León Suárez I, Darsow U, Ruëff F, Behrendt H, Ring J. A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin. Exp. Allergy 40, 411-418 (2010).
21. De Week AL, Sanz ML, Gamboa PM et al. Diagnosis of immediate-type b-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study. J. Investig. Allergol. Clin. Immunol. 19, 91-109 (2009).
22. Brockow K, Romano A, Aberer W et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media-a European multicenter study. Allergy 64, 234-241 (2009).
23. Caimmi S, Benyahia B, Suau D et al. Clinical value of negative skin tests to iodinated contrast media. Clin. Exp. Allergy 40, 805-810 (2010).
24. Garvey LH, Kroigaard M, Poulsen LK et al. IgE-mediated allergy to chlorhexidine. J. Allergy Clin. Immunol. 120, 409-415 (2007). (Pubitemid 47102385)
25. Ebo DG, Bridts CH, Stevens WJ. IgE-mediated anaphylaxis from chlorhexidine: diagnostic possibilities. Contact Dermatitis 55, 301-302 (2006). (Pubitemid 44536308)
26. Ebo DG, Bosmans JL, Couttenye MM, Stevens WJ. Haemodialysis-associated anaphylactic and anaphylactoid reactions. Allergy 61, 211-220 (2006). (Pubitemid 43381833)
27. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000 Anesthesiology 99, 536-545 (2003). (Pubitemid 37051967)
28. Leysen J, Bridts CH, De Clerck LS et al. Allergy to rocuronium: from clincial suspicion to correct diagnosis. Allergy DOI: 101111/j.1398- 9995201102569x (2011) (Epub ahead of print).
29. Mertes PM, Aimone-Gastin I, Gueant- Rodriguez RM et al. Hypersensitivity reactions to neuromuscular blocking agents. Curr. Pharm. Des. 14, 2809-2825 (2008).
30. Ebo DG, Bridts CH, Hagendorens MM, Mertens CH, De Clerck LS, Stevens WJ. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy 61, 935-939 (2006). (Pubitemid 44024890)
31. Blanca M, Romano A, Torres MJ et al. Update on the evaluation of hypersensitivity reactions to b lactams. Allergy 64, 183-193 (2009).
32. Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr. Allergy Asthma Rep. 5, 15-21 (2005). (Pubitemid 40310252)
33. Venturini M, Lobera T, del Pozo Gil MD, Blasco A, Gonzalez I. In vivo diagnostic tests in adverse reactions to quinolones. J. Investig. Allergol. Clin. Immunol. 17, 393-398 (2007). (Pubitemid 350232564)
34. Aranda A, Mayorga C, Ariza A et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 66(2), 247-254 (2010).
35. Bavbek S, Ikinciogullari A, Dursun AB et al. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int. Arch. Allergy Immunol. 150, 261-270 (2009).
36. Celik GE, Schroeder JT, Hamilton RG, Saini SS, Adkinson NF. Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin. Exp. Allergy 39, 1522-1531 (2009).
37. Malbran A, Yeyati E, Rey GL, Galassi N. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin. Exp. Immunol. 147, 99-105 (2007). (Pubitemid 44915560)
38. De Weck AL, Sanz ML, Gamboa PM et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. J. Investig. Allergol. Clin. Immunol. 19, 355-369 (2009).
39. De Weck AL, Sanz ML, Gamboa PM et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. J. Investig. Allergol. Clin. Immunol. 20, 39-57 (2010).
40. Gamboa P, Sanz ML, Caballero MR et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin. Exp. Allergy 34, 1448-1457 (2004). (Pubitemid 39233702)
41. Sanz ML, Gamboa PM, Mayorga C. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 9, 298-304 (2009).
42. Gomez E, Blanca-Lopez N, Torres MJ et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin. Exp. Allergy 39, 1217-1224 (2009).
43. Gamboa PM, Sanz ML, Caballero MR et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 58, 312-317 (2003). (Pubitemid 36566749)
44. Fernandez TD, Torres MJ, Blanca-Lopez N et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 64, 242-248 (2009).
45. Sturm GJ, Kranzelbinder B, Sturm EM, Heinemann A, Groselj-Strele A, Aberer W. The basophil activation test in the diagnosis of allergy: technical issues and critical factors. Allergy 64, 1319-1326 (2009).
46. Sturm EM, Kranzelbinder B, Heinemann A, Groselj-Strele A, Aberer W, Sturm GJ. CD203c-based basophil activation test in allergy diagnosis: characteristics and differences to CD63 upregulation. Cytometry B Clin. Cytom. 78, 308-318 (2010).
47. Ebo DG, Stevens WJ, Bridts CH, Matthieu L. Contact allergic dermatitis and life-threatening anaphylaxis to chlorhexidine. J. Allergy Clin. Immunol. 101, 128-129 (1998). (Pubitemid 28112893)
48. Rubio M, Bousquet PJ, Demoly P. Update in drug allergy: novel drugs with novel reaction patterns. Curr. Opin. Allergy Clin. Immunol. 10, 457-462 (2010).
49. Sainte-Laudy J, Vallon C, Guerin JC. Libération de l'histamine par le basophile humain induite par les métabisulfites. Effets de l'IL-3 Rev. Fr. Allergol. 34, 67-68 (1994).
50. Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435 J. Allergy Clin. Immunol. 88, 328-338 (1991).
51. Buhring HJ, Simmons PJ, Pudney M et al. The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood 94, 2343-2356 (1999). (Pubitemid 29467682)
52. MacGlashan D. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin. Exp. Allergy 40, 1365-1377 (2010).
53. Ebo DG, Hagendorens MM, Bridts CH et al. The basophil activation test in immediate drug allergy. Acta Clin. Belg. 64, 129-35 (2009).
54. Rodriguez-Trabado A, Camara-Hijon C, Ramos-Cantarino A et al. Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity. Allergy Asthma Proc. 29, 241-249 (2008).